Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-blind, Crossover Study to Assess the Injection Site Pain Associated With a Modified Etanercept Formulation in Adult Subjects With Either Rheumatoid Arthritis or Psoriatic Arthritis

NCT02986139 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT02986139
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02986139 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-blind, Crossover Study to Assess the Injection Site Pain Associated With a Modified Etanercept Formulation in Adult Subjects With Either Rheumatoid Arthritis or Psoriatic Arthritis
Lead sponsor
Amgen
Phase
Phase 3
Overall status
Completed
Start date
November 29, 2016
Completion date
October 9, 2017
Enrollment
111 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

arthritis, rheumatoid; arthritis, psoriatic